Study Objective: To compare clinical and microbiologic outcomes in adults without cystic fibrosis who had Pseudomonas aeruginosa bronchial colonization and were receiving inhaled colistin or colistin plus tobramycin with those who were receiving inhaled tobramycin as outpatient treatment.
Design: Prospective, observational cohort study.
Setting: Referral pneumology service at a tertiary university care hospital.